OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparative Efficacy and Safety of Biological Agents in the Treatment of Lupus Nephritis: A Network Meta-Analysis
Young Ho Lee, Gwan Gyu Song
Pharmacology (2022) Vol. 108, Iss. 1, pp. 17-26
Open Access | Times Cited: 7
Young Ho Lee, Gwan Gyu Song
Pharmacology (2022) Vol. 108, Iss. 1, pp. 17-26
Open Access | Times Cited: 7
Showing 7 citing articles:
Efficacy and safety of biologics, multitarget therapy, and standard therapy for lupus nephritis: a systematic review and network meta-analysis
Gui-Qing Tian, Zhenqiong Li
Renal Failure (2024) Vol. 46, Iss. 2
Open Access | Times Cited: 2
Gui-Qing Tian, Zhenqiong Li
Renal Failure (2024) Vol. 46, Iss. 2
Open Access | Times Cited: 2
Pancytopenia as a first presentation of late-onset systemic lupus erythematosus: a case report
Ghina Haidar, Naram Khalayli, Tasneem Drie, et al.
Annals of Medicine and Surgery (2024)
Open Access | Times Cited: 1
Ghina Haidar, Naram Khalayli, Tasneem Drie, et al.
Annals of Medicine and Surgery (2024)
Open Access | Times Cited: 1
Therapeutically targeting proinflammatory type I interferons in systemic lupus erythematosus: efficacy and insufficiency with a specific focus on lupus nephritis
Benjamin Lai, Shue‐Fen Luo, Jenn-Haung Lai
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Benjamin Lai, Shue‐Fen Luo, Jenn-Haung Lai
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Low-dose interleukin-2 treatment increases the proportion of regulatory T cells in patients with rheumatic diseases: A meta-analysis
Huanhuan Yan, Huer Yan, Lu Liu, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 3, pp. 103270-103270
Closed Access | Times Cited: 3
Huanhuan Yan, Huer Yan, Lu Liu, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 3, pp. 103270-103270
Closed Access | Times Cited: 3
Efficacy and safety of belimumab therapy for patients with lupus nephritis: A meta‐analysis and a propensity score‐matched case–control study
Kai Zhang, Tiening Qi, Guo Donghua, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 7
Open Access | Times Cited: 2
Kai Zhang, Tiening Qi, Guo Donghua, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 7
Open Access | Times Cited: 2
Biologicals for the treatment of lupus nephritis: a Bayesian network meta-regression analysis
Xi Liu, Xiaoli Chen, Cheng-yin Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Xi Liu, Xiaoli Chen, Cheng-yin Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Nefritis Lúpica : Una Revisión Sistemática de su Manejo
María Isabel Bojorquez Ortiz, Izabel Paola Hernández Cabrera
Revista de la Facultad de Medicina (2024) Vol. 2, Iss. 1, pp. 46-67
Open Access
María Isabel Bojorquez Ortiz, Izabel Paola Hernández Cabrera
Revista de la Facultad de Medicina (2024) Vol. 2, Iss. 1, pp. 46-67
Open Access
